Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Neonc Technologies, Inc.
Neonc Technologies, Inc.
Seoul National University Bundang Hospital
Azienda Ospedaliero-Universitaria di Parma
Ocellaris Pharma, Inc.
Mayo Clinic